Expert Illustrations & Commentaries™: Visualizing Corneal Innervation, Pathophysiology, and Treatment Mechanisms in Neurotrophic Keratitis

Release Date: December 23, 2021
Expiration Date: December 23, 2022

Activity Overview

Acknowledgement of Commercial Support

This activity is supported by educational grants from Dompé.
 

Target Audience

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe the pathophysiology of NK as related to corneal sensory innervation
• Classify the stages of NK based on corneal signs
• Apply appropriate patient assessments to provide prompt diagnosis of NK
• Assess the effect of therapy on the NK disease process
• Discuss safety and efficacy data for approved and traditionally used therapies for NK
   

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies. 
 

Chair

Anthony J. Aldave, MD
Professor of Ophthalmology
Walton Li Chair in Cornea and Uveitis
Chief, Cornea and Uveitis Division
Director, Cornea and Refractive Surgery Fellowship Program
The Jules Stein Eye Institute
David Geffen School of Medicine at UCLA
Los Angeles, CA
 

Disclosures: Consultant: Dompé; Speakers’ Bureau: Dompé
 

Faculty

 

Clara C. Chan, MD, FRCSC, FACS, DABO
Assistant Professor
Department of Ophthalmology & Vision Sciences
University of Toronto
Medical Director
Eye Bank of Canada
Toronto, Ontario, Canada

Disclosures: Grant/Research Support: Allergan, Bausch & Lomb, Shire, Novartis; Consultant: Aequus, Allergan, Labtician Théa, ZEISS, Santen, Novartis, Sun Pharma; Speaker’s Bureau: Allergan, Johnson & Johnson, Novartis, Labtician Théa; Stock/Shareholder: Pfizer.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.